Matinas BioPharma updates corporate presentation for investor meetings

Matinas BioPharma Holdings, Inc.

Corporate presentation updated as of September 20, 2023 for use at conferences.
No specific financial or operational details disclosed in the filing body.
Investors should review the exhibit for any changes to strategy or pipeline.

item 7.01 item 9.01

Matinas BioPharma Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-033131

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.